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Abstract. Recently, two techniques, polymerase chain reaction (PCR) amplification and sequencing of cytochrome
b gene (cyt b gene sequencing) and polymorphism-specific PCR (PS-PCR) were recommended for Leishmania species
identification. Before this study, however, the accuracy of these methods had not been tested against the multilocus
enzyme electrophoresis, the current gold standard technique on this task. Therefore, a trial was done for the first time
to compare the results obtained by these techniques, using 17 Argentinean Leishmania stocks in independent assays. For
all the stocks examined, the same results at species level were obtained by the three techniques. Among them, 14 were
assigned to L. (Viannia) braziliensis, and three to L. (V.) guyanensis. The two techniques, cyt b gene sequencing and
PS-PCR, were able to distinguish between all the proven species responsible for leishmaniases in Argentina. Thus, both
techniques were validated and could be used independently for the species designation of Leishmania parasites in the
country.
INTRODUCTION
The leishmaniases are parasitic diseases that threaten 350
million people in 88 countries on 4 continents, with an annual
incidence of new cases estimated between 1.5 and 2 million.
They are caused by protozoan flagellates that belong to
Leishmania genus, which includes around 30 taxa.1 There is
no direct correlation between these Leishmania species and
the specific clinical patterns induced except several cases,2
and they have shown different responses to the chemo-
therapy.3 In addition, it is common for different species to
coexist in the same endemic areas, as seen in Argentina,
where Leishmania (Viannia) braziliensis, L. (V.) guyanensis,
and L. (Leishmania) amazonensis have been incriminated as
the causative agents of human leishmaniases by molecular
methods to date.4–9 In particular, substantial evidence exists
that the diseases caused by L. (V.) braziliensis and L. (V.)
guyanensis differ in their clinical presentation, diagnostic ap-
proach required, and therapeutic response to antimonials.10,11
For these reasons, the Leishmania spp. discrimination is
important not only from an epidemiologic perspective but
also from the clinical ones to improve the patients’ prognosis,
diagnostic methods, and to monitor clinical outcomes.12,13
Moreover, the accurate identification of these parasites must
be based on molecular approaches because parasitological,
clinical, or epidemiologic features are by themselves insuffi-
cient for this task.14
Among the molecular methods applied on the Leishmania
spp. identification, the DNA-based techniques have been
used increasingly. One of them, the polymerase chain reac-
tion (PCR) amplification and sequencing of cytochrome b
gene method (cyt b gene sequencing) has recently been es-
tablished as a useful tool for the identification and phyloge-
netic studies of the Leishmania genus, being able to differen-
tiate among the species and from other trypanosomatids.15
Another of these techniques, the polymorphism-specific PCR
(PS-PCR), has been used for the Leishmania spp. identifica-
tion based on the presence of bands amplified for subgenus or
species-specific primers, without requiring other proce-
dures.16
Since both cyt b gene sequencing and PS-PCR, as with the
other DNA-based techniques, have some advantages over the
classically used techniques on the Leishmania spp. identifica-
tion, such as isoenzymes, serodemes, or schizodeme analy-
sis,12 they may have an advantage of the application in field
work, particularly in Argentina. However, to be used widely
as reliable and effective methods, it is necessary to evaluate
their efficacy in restricted endemic areas.17
This article reports for the first time a double-blind assay
designed to test the accuracy of the cyt b gene sequencing and
PS-PCR methods on Leishmania spp. identification, com-
pared with multilocus enzyme electrophoresis (MLEE), the
current gold standard technique,1 using a panel of Argen-
tinean Leishmania isolates, as a required step in their optimi-
zation. The results are discussed in terms of the probable
applications of these techniques, highlighting their advan-
tages, on the areas of diagnosis, clinico-pathology, and epide-
miology of leishmaniases in Argentina.
MATERIALS AND METHODS
Parasites. Seventeen Leishmania stocks, characterized by
MLEE analyzing 12 loci, were included in this study. Sixteen
of them were isolated in the northern areas of Argentina, one
from a canine and 15 from humans, all American tegumen-
tary leishmaniasis (ATL) cases. Their enzymatic profiles, phy-
logenetic relationships, and clinico-epidemiologic character-
istics were reported previously.4 The remaining isolate,
named MHOM/AR/99/DMZ, was obtained from the stock
MHOM/AR/99/JDM1 after performing culture-mouse pas-
sages 4 times, as follows: JDM1 promastigotes were cultured
for 10 ds in 10 mL of sterile liver infusion tryptose medium
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supplemented with 100 U/mL Penicillin and 50 g/mL Strep-
tomycin (PE), 20% heat inactivated fetal bovine serum
(hiFBS).18 They were harvested and 0.05 mL of a suspension
at 20.107 promastigotes/mL was inoculated into right footpads
of 4-week-old mice. After 3 weeks of inoculation, the footpad
tissue was aseptically removed, homogenized, and cultured
again in the same medium. This procedure was repeated 4
times.
Five World Health Organization (WHO) reference strains:
L. (V.) braziliensis, HOM/BR/75/M2904; L. (V.) panamensis,
MHOM/PA/71/LS94; L. (V.) guyanensis, MHOM/BR/75/
M4147; L. (L.) amazonensis, MHOM/BR/73/M2269; L. (L.)
mexicana, MNYC/BZ/62/M379; and one L. (V.) braziliensis
Ecuadorian strain: MHOM/EC/88/INH-03 were used as con-
trols.
Samples preparation for DNA analysis. Promastigotes of
each isolate were cultured in RPMI 1640 medium supple-
mented with PE and 10% of hiFBS, diluting gradually to a
final volume of 8 mL for 7 ds. Two tubes for each isolate were
done. After washing 4 times (2,500 rpm, 10 minutes) with
sterile PBS, 2 mL of TE buffer (10 mM Tris-HCl, pH  8,
1 mM EDTA) or 99% ethanol were added to the pellet of
each tube. These samples were aliquoted and stored at −20°C
until use. This procedure was carried out at the same time that
the pellets of promastigotes for MLEE were prepared.
Detection of cytochrome b gene using polymerase chain
reaction. To extract the genomic DNA from each of the
samples prepared, a genomic extraction kit (i.e., Genomic
Prep Cell and Tissue DNA Isolation Kit (Amersham-
Biosciences, USA)) was used, following the protocol and
methods described by the company. The PCR was performed
with Ex-Taq polymerase (Takara, Japan) under the following
conditions: initial denaturation at 94°C for 3 minutes followed
by 35 cycles of 94°C for 1 minute, 50°C for 1 minute, and 72°C
for 1 minute. Two hundred ng of parasite DNA as a template,
LCBF1 forward primer (5-GGTGTAGGTTTTAGTYT-
AGG-3), and LCBR2 reverse primer (5-CTACAATAAA-
CAAATCATAATATRCAATT-3) were used for the cyt b
gene amplification. The PCR products were visualized on a
1% agarose gel.
Cytochrome b gene direct sequencing procedures. The cyt
b gene sequences for each sample were determined following
the procedure described previously.15,19 Briefly, the amplified
fragments, obtained as was described previously, were elec-
trophoresed on 1% Seakam GTG agarose gel (FMC, USA),
excised, and then purified by using the QIA quick Gel Ex-
traction kit (Qiagen, USA). The purified DNA was examined
by direct sequencing with the Big Dye Terminator Cycle Se-
quencing kit (PE Biosystems, USA) and ABI PRISMTM 310
Genetic Analyzer. The sequencing primers used were
LCBF1, LCBR2, LCYT B F4L (5-TGTTATTGAATAT-
GAGGTAGTG-3) and LCYT B R4 (5-GAACTCAT-
AAAATAATGTAAACAAAA-3). The obtained se-
quences, assembled and edited by Genetyx Mac 11.0.0 (Soft-
ware Development Co. Ltd, Japan) were compared with the
reference strain ones, available from DDBJ/EMBL/
GeneBank nucleotide sequence databases with accession
numbers from AB095957 to AB095970.
Polymorphism-specific polymerase chain reaction proce-
dures. The DNA samples obtained from the Leishmania
stocks as was described previously were centrifuged at 8000
rpm for 5 minutes and the pellets were treated with Insta-
Gene Matrix (Bio Rad, Hercules, CA). A dilution of 1/100 in
MilliQ water of the resulting materials termed “InstaGene
DNA preparations”, was used as template and subjected to
PCR procedures in a GeneAmp PCR System 2400 (Perkin–
Elmer, Wellesley, MA) using Roche GeneAmp XL PCR Kit
(Applied Biosystems, Foster City, CA), at a final volume of
15 L. For Leishmania subgenus identification, the following
conditions were applied: after initial denaturation at 95°C for
5 minutes, 35 cycles (30 seconds at 95°C, 30 seconds at 60°C,
30 seconds at 72°C) in the first step. This procedure was car-
ried out using the V1 (5-GCTTCTCGTTTCGCTTTGAAC-
3)– V2 (5-CAAGACAAGAAAAAAGGCGGC-3) for
the detection of L. (Viannia), and L1 (5-GGTCACTCG-
GCATTTTTGC-3)–L2 (5-GTGCCCTGACTTGCAT-
GTCTA-3) for L. (Leishmania) subgenus.
In the second step, PS-PCR was performed under the fol-
lowing condition: 37 cycles (30 seconds at 95°C, annealing
for 90 seconds at 70°C for the L. (Viannia) group or 60°C
for the L. (Leishmania) group, and extension for 90 sec-
onds at 72°C), using the primers as follows: b1 (5-
GTGGGCGTATCTGCTGATGAC-3)–b2 (5-CAA-
AAAGCGAGGGACTGCGGA-3) for L. (V.) braziliensis,
p1 (5-GGTCGGATCTGCATGCATCAC-3)–p2 (5-
CAAAAAGCGAGGGACTGCGGG-3) for L. (V.) pana-
mensis, g1 (5-GGTCGGATCTGCATGCATCAT3)–g2 (5-
CAAAAAGCGAGGGACTGCGGG-3) for L. (V.) guyan-
ensis, m1 (5-TGCGAGGATAAAGGGAAAGAG-3)–m2
(5-GTGCCCTGACTTGCATGTCTA-3) for L. (L.) mexi-
cana, and a1 (5-TGCGAGGATAAAGGGAAAGAA-3)–
a2 (5-GTGCCCTGACTTGCATGTCTA-3) for L. (L.)
amazonensis.
The PCR products were separated on 2% agarose gels con-
taining ethidium bromide.
Statistical analysis. To statistically analyze the association
between the zymodemes and cyt b sequences, the Fisher’s
exact test was used.
RESULTS
The species assignation of a panel of 17 Argentinean Leish-
mania stocks and 5 WHO reference strains was performed by
cyt b gene sequencing and PS-PCR in independent determi-
nations, as is shown in Table 1.
All these parasites were characterized by MLEE analyzing
12 enzymatic loci. Their enzymatic profiles, phylogenetic re-
lationships, and clinico-epidemiologic characteristics have
been reported previously.4 Briefly, 14 of the Argentinean
Leishmania stocks expressed 3 zymodemes, and termed KMS
1 to KMS 3, were assigned to L. (V.) braziliensis. These zy-
modemes differed from the ones expressed for the WHO
reference strains. Two other stocks, grouped in the zymo-
deme KMS 4, were identified as L. (V.) guyanensis.4 The
remaining isolate, MHOM/AR/99/DMZ, also expressed this
last zymodeme (data not shown).
Cytochrome b gene sequencing analysis. On the panel of
Argentinean Leishmania isolates, the cyt b gene amplification
was performed applying PCR with LCBF1 and LCBR2 prim-
ers (Figure 1).15 The 866 bp DNA fragments obtained for
each one of the samples were sequenced and compared with
the cyt b gene sequences of WHO Leishmania reference
strains available from DDBJ/EMBL/GeneBank nucleotide
sequence databases. Fourteen of these isolates were assigned
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to L. (L.) braziliensis, since the two cyt b gene sequences
found, named Ab-1 (5) and Ab-2 (9), showed 99.87% and
99.75% similarity to the MHOM/EC/88/INH-03 L. (V.) bra-
ziliensis strain sequence (GeneBank accession No.
AB095967). The sequences Ab-1 and Ab-2 differed by only
one nucleotide base (Figure 2). Statistically, no association
between the zymodemes reported and the present sequences
was found (P > 1.00). A third cyt b gene sequence found, and
shown for the remaining 3 stocks of the panel, was indistin-
guishable from the L. (V.) guyanensis reference strain
MHOM/BR/75/M4147 sequence (GeneBank accession No.
AB095969, Table 1).
Leishmania species identification by polymorphism-
specific polymerase chain reaction. This analysis is based on
the occurrence of either Leishmania subgenus or species-
specific PCR products corresponding to DNA fragments,
which had originally been amplified by arbitrarily primed
PCR.16 First, the samples were simultaneously tested in sepa-
rate reactions, with Leishmania subgenus-specific primers.
All the isolates of the Argentinean panel were identified as L.
(Viannia) subgenus, since a 168-bp PCR-product with V1-V2
primers, but none with L1-L2 primers were detected. A 78-bp
band with the L1-L2 primers was only observed for the WHO
reference strains belonging to the L. (Leishmania) subgenus
used in this study. In the second step, the species identifica-
tion was performed using primers b1-b2, p1-p2, and g1-g2 for
the samples identified as L. (Viannia) subgenus or a1-a2 and
m1-m2 for the strains revealed as L. (Leishmania) subgenus.
Thus, a 103-bp PCR-product with the primers b1-b2, but none
with the other two pairs of primers was seen in 14 of the
Argentinean samples; therefore, they were identified as L.
(V.) braziliensis. The 3 remaining stocks were assigned to L.
(V.) guyanensis, since only a 79-bp band with the primers
g1-g2 was seen. (Table 1, Figure 3).
Both, cyt b gene sequencing and PS-PCR have agreed with
MLEE on the Leishmania species identification for each one
of the stocks and strains analyzed (Table 1).
DISCUSSION
The clinico-epidemiologic relevancy of the Leishmania spe-
cies identification has induced the development and improve-
ment of new molecular tools such as cyt b gene sequencing
and PS-PCR, which, as another DNA-based tool, may have
many advantages over the classically used methods.12,15,16
However, it becomes necessary to test their accuracy on this
task comparing with the gold standard technique, a validation
assay, as an important previous step in their optimization for
FIGURE 1. Polymerase chain reaction (PCR) products obtained
with the primers LCBF1 and LCBR2 for the 17 Argentinean Leish-
mania isolates. Lane M: size marker (100 bp ladder, BioLabs inc, New
England); lane 1, LP01; lane 2, NSS3; lane 3, LBC1; lane 4, DMZ;
lane 5, JDM1; lane 6, AZ3; lane 8, OLO1; lane 9, MR02a; lane 10,
MR02b; lane 11, HN03; lane 12, HN03; lane 13, FD04; lane 14, CF05;
lane 15, MAS5, lane 16, AAS4; lane 17, MAS5; lane 18, RLS6; lane
7 and 19, negative controls. Arrow shows 886 bp (expected amplicon
size). For isolates identification see Table 1.
TABLE 1
Species differentiation by three techniques: multilocus enzyme electrophoresis (MLEE) analysis, polymerase chain reaction (PCR) amplification
and sequencing of cytochrome b gene (cyt b gene sequencing), and polymorphism-specific PCR (PS-PCR) of 17 Argentinean Leishmania stocks
Stocks designation
Species
assignation* Zymodeme
Cyt b
gene
sequence
PS-PCR‡
Clinical
formV L p b g a m
Argentinean isolates
MHOM/AR/99/AZ3 L. (V.) br KMS 1 Ab-1 + − − + − − − CL
MHOM/AR/02/RLS6 L. (V.) br KMS 1 Ab-2 + − − + − − − CL
MHOM/AR/02/NSS3 L. (V.) br KMS 1 Ab-1 + − − + − − − MCL
MHOM/AR/02/MAS5a L. (V.) br KMS 1 Ab-2 + − − + − − − CL
MHOM/AR/02/MAS5b L. (V.) br KMS 1 Ab-2 + − − + − − − CL
MHOM/AR/03/AAS4 L. (V.) br KMS 1 Ab-1 + − − + − − − MCL
MHOM/AR/03/OLO1 L. (V.) br KMS 1 Ab-1 + − − + − − − CL
MHOM/AR/03/MRO2a L. (V.) br KMS 1 Ab-2 + − − + − − − CL
MHOM/AR/03/MRO2b L. (V.) br KMS 1 Ab-2 + − − + − − − CL
MHOM/AR/03/HNO3a L. (V.) br KMS 2 Ab-2 + − − + − − − CL
MHOM/AR/03/HNO3b L. (V.) br KMS 2 Ab-2 + − − + − − − CL
MHOM/AR/03/FDO4 L. (V.) br KMS 2 Ab-1 + − − + − − − CL
MHOM/AR/03/CFO5 L. (V.) br KMS 2 Ab-2 + − − + − − − RCL
MCAN/AR/02/LPO1 L. (V.) br KMS 3 Ab-2 + − − + − − − CL
MHOM/AR/98/LBC1 L. (V.) gu KMS 4 AB095969† + − − − + − − CL
MHOM/AR/99/JDM1 L. (V.) gu KMS 4 AB095969 + − − − + − − CL
MHOM/AR/99/DMZ L. (V.) gu KMS 4 AB095969 + − − − + − − CL
Reference strains
MHOM/BR/75/M4147 L. (V.) gu KMS 4 AB095969 + − − − + − − CL
MNYC/BZ/62/M379 L. (L.) me KMS 5 AB095963 − + − − − − + CL
MHOM/BR/73/M2269 L. (L.) am KMS 6 AB095964 − + − − − + − CL, DCL
MHOM/BR/75/M2904 L. (V.) br KMS 7 AB095966 + − − + − − − CL
MHOM/PA/71/LS94 L. (V.) pa KMS 8 AB095968 + − + − − − − CL
L. (V.) br, Leishmania (Viannia) braziliensis; L. (V.) gu, L. (V.) guyanensis; L. (V.) pa, L. (V.) panamensis; L. (L.) am, L. (Leishmania) amazonensis; L. (L.) me, L. (L.) mexicana; KMS, Kochi
Medical School; CL, cutaneous leishmaniasis; MCL, mucocutaneous leishmaniasis; RCL, recurrent cutaneous leishmaniasis; DCL, diffuse cutaneous leishmaniasis.
* Done separately by MLEE, cyt b gene sequencing, and PS-PCR; †GeneBank accession numbers of the cyt b sequences; ‡The pair of primers V and L were used for Viannia and Leishmania
subgenus differentiation, respectively. The pairs of primers p, b, g, a, and m were used for detection of panamensis, braziliensis, guyanensis, amazonensis, and mexicana species, respectively.
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applying them in field studies. Besides, the tremendous diver-
sity that exists in the Leishmania genus necessitates the com-
parison, using local Leishmania isolates from the geographic
areas in which the novel techniques are going to be applied.20
Under this context, in the current study it was proven that
the cyt b gene sequencing and PS-PCR methods precisely
identified the Leishmania spp. for each one of the local stocks
well characterized by MLEE, the gold standard technique,
and that they were able to differentiate among the 3 proven
species responsible for ATL in Argentina: L. (V.) braziliensis,
L. (V.) guyanensis, and L. (L.) amazonensis.4–9 In addition,
the cyt b gene sequences have shown clear interspecific dif-
ferences,15 but high homogeneity among the zymodemes of
the two local species analyzed, allowing an accurate species
differentiation.
Therefore, these two techniques were validated and could
have an application on the species identification of ATL cau-
sal agents in this country.
Among the properties of these two molecular methods sup-
porting their applicability in field studies, it should be high-
lighted that they may not require the isolation and mass cul-
tivation of the parasites, since they can be performed on
samples taken directly from the patient (host) lesions and
tissues, or from vectors,19,21 in contrast with the huge amount
of parasites required by MLEE method; the two methods
need relatively shorter times than MLEE for processing; and
in the case of PS-PCR, the technique could be applied in
laboratories of relatively few resources to analyze great num-
bers of samples. Nevertheless, the application of the PS-PCR
method is only restricted to the differentiation of the 5 major
Leishmania spp.- braziliensis, guyanensis, panamensis, ama-
zonensis, and mexicana, responsible for ATL. In the case of
the cyt b gene sequencing, it could be used for molecular
phylogenetic relationship analysis, as a second-line technique
in the identification of samples in which the PS-PCR tech-
nique may not be conclusive, as in the possible appearance of
a Leishmania spp. out of its range, or for the confirmation of
very relevant cases.15,19
In conclusion, both the cyt b gene sequencing and the PS-
PCR techniques showed a total agreement with MLEE, the
current gold standard method on the identification of Leish-
mania spp. on a panel of Argentinean isolates. Hence, this is
evidence that their results concerning the present task are
very reliable, representing an advantage in the study of the
leishmaniases in Argentina, where simple, field-applicable,
and reliable diagnostic techniques are extremely necessary.
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